Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

ARNOLD & PORTER KAYE SCHOLER LLP filed a Q3 report for SUMITOMO PHARMA AMERICA, INC. on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for SUMITOMO PHARMA AMERICA, INC. · Manufacturer of oncology, rare disease, CNS, urology, and women's health treatments.

All filings by ARNOLD & PORTER KAYE SCHOLER LLP · Everything SUMITOMO PHARMA AMERICA, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.

Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem